TYDISIL

This brand name is authorized in Nigeria.

Active ingredients

The drug TYDISIL contains one active pharmaceutical ingredient (API):

1	Terbinafine UNII G7RIW8S0XP - TERBINAFINE
	Terbinafine is an allylamine which has a broad spectrum of antifungal activity. Terbinafine acts by inhibition of squalene epoxidase in the fungal cell membrane. At low concentrations terbinafine is fungicidal against dermatophytes, moulds and certain dimorphic fungi. The activity versus yeasts is fungicidal or fungistatic depending on the species.
	Read more about Terbinafine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100352	Tablet	Tydisil Tablet TAB 250 mg 2 X 7	NF-PP-173121 Tydisil Tablet Terbinafine Hydrochloride 250mg Terbinafine Hydrochloride USP Eq. to Terbinafine Antifungals 281.27 Microcrystalline Cellulose BP Diluent 220.73 Colloidal anhydrous silica BP Glidant 5.000 Binding Hydroxy propyl methyl cellulose BP Binder 25.000 Isopropyl alcohol BP Solvent 0.058 ml Methylene Chloride BP Vehicle 0.058 ml Blending & Lubrication Magnesium stearate BP Lubricant 3.000 Purified Talc BP Glidant 5.000 Sodium starch glycolate BP Disintegrant 10.000 A4-100352 Drugs DERMATOLOGICALS Imported Products 27 POM 1 10/26/2020 OSWORTH NIGERIA LIMITED, SAPARA STREET, INDUSTRIAL ESTATE, P.M.B. 21049 IKEJA IKEJA LAGOS 18980080 temitope_oreoluwa@yahoo.co.uk M/S STALLION LABORATORIES PVT LTD., C1 B305/2, 3, 4 & 5, GIDC., KERALA(BAVLA), DIST.-AHMEDABAD-382 220., India	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D01BA02	Terbinafine	D Dermatologicals → D01 Antifungals for dermatological use → D01B Antifungals for systemic use → D01BA Antifungals for systemic use
Discover more medicines within D01BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100352